Epilepsy Surgery Articles & Analysis
4 news found
“About a third of individuals with epilepsy have drug-resistant seizures. Removal or ablation of the affected temporal lobe can be an option, but many people with epilepsy are not eligible or interested in a tissue-destructive procedure. ...
Patient recruitment is underway at epilepsy centers across the United States. About NRTX-1001 NRTX-1001 is a regenerative neural cell therapy derived from human pluripotent stem cells. ...
Prior to working in the pharmaceutical industry, he was in clinical practice as a neurologist at the Barrow Neurological Institute in Arizona for 10 years, where he was director of the epilepsy program. He has authored or co-authored over 50 full-length papers in neurology-related areas. ...
The data are being presented at the Annual Meeting of the American Epilepsy Society (AES), which is being held December 3-7, 2021, in Chicago, IL. “These preclinical data, in a model of drug-resistant epilepsy, demonstrate that a single administration of NRTX-1001 achieves durable and significant suppression of seizures and reduction of hippocampal ...